Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2008 3
2009 2
2010 3
2011 1
2012 3
2013 18
2014 19
2015 16
2016 11
2017 10
2018 13
2019 18
2020 17
2021 19
2022 27
2023 20
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
Immuno-Surgical Management of Pancreatic Cancer with Analysis of Cancer Exosomes.
Takeda Y, Kobayashi S, Kitakaze M, Yamada D, Akita H, Asai A, Konno M, Arai T, Kitagawa T, Ofusa K, Yabumoto M, Hirotsu T, Vecchione A, Taniguchi M, Doki Y, Eguchi H, Ishii H. Takeda Y, et al. Among authors: akita h. Cells. 2020 Jul 9;9(7):1645. doi: 10.3390/cells9071645. Cells. 2020. PMID: 32659892 Free PMC article. Review.
Clinical Impact of Enhanced Recovery After Esophagectomy in Patients With Esophageal Cancer.
Sugase T, Kanemura T, Takeoka T, Urakawa S, Sugimura K, Masuike Y, Shinno N, Hara H, Omori T, Kitakaze M, Kubo M, Mukai Y, Sueda T, Hasegawa S, Akita H, Nishimura J, Wada H, Yasui M, Miyata H. Sugase T, et al. Among authors: akita h. Anticancer Res. 2023 Sep;43(9):4197-4205. doi: 10.21873/anticanres.16611. Anticancer Res. 2023. PMID: 37648293
Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma.
Matsushita K, Kobayashi S, Akita H, Konno M, Asai A, Noda T, Iwagami Y, Asaoka T, Gotoh K, Mori M, Doki Y, Eguchi H, Ishii H. Matsushita K, et al. Among authors: akita h. Cancer Rep (Hoboken). 2022 Oct;5(10):e1582. doi: 10.1002/cnr2.1582. Epub 2021 Nov 24. Cancer Rep (Hoboken). 2022. PMID: 34821071 Free PMC article.
Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients With Resectable and Borderline Resectable Pancreatic Cancer: Long-term Conditional Recurrence-free Survival Analysis in the Setting of a Neoadjuvant Treatment Strategy.
Takahashi H, Akita H, Wada H, Miyata H, Eguchi H, Ohigashi H, Sakon M, Ishikawa O. Takahashi H, et al. Among authors: akita h. Ann Surg. 2023 Dec 1;278(6):e1216-e1223. doi: 10.1097/SLA.0000000000005879. Epub 2023 Apr 14. Ann Surg. 2023. PMID: 37057622
Self-assembling peptide hydrogel SPG-178 as a pancreatic fistula-preventing agent.
Mikamori M, Gotoh K, Kobayashi S, Uesugi K, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Noda T, Doki Y, Eguchi H. Mikamori M, et al. Among authors: akita h. Langenbecks Arch Surg. 2022 Feb;407(1):189-196. doi: 10.1007/s00423-021-02226-5. Epub 2021 Jun 7. Langenbecks Arch Surg. 2022. PMID: 34100123
Factors Affecting Nonfunctioning Small Pancreatic Neuroendocrine Neoplasms and Proposed New Treatment Strategies.
Hijioka S, Yamashige D, Esaki M, Honda G, Higuchi R, Masui T, Shimizu Y, Ohtsuka M, Kumamoto Y, Katanuma A, Gotohda N, Akita H, Unno M, Endo I, Yokoyama Y, Yamada S, Matsumoto I, Ohtsuka T, Hirano S, Yasuda H, Kawai M, Aoki T, Nakamura M, Hashimoto D, Rikiyama T, Horiguchi A, Fujii T, Mizuno S, Hanada K, Tani M, Hatori T, Ito T, Okuno M, Kagawa S, Tajima H, Ishii T, Sugimoto M, Onoe S, Takami H, Takada R, Miura T, Kurita Y, Kamei K, Mataki Y, Okazaki K, Takeyama Y, Yamaue H, Satoi S; Japan Pancreas Society Clinical Research Promotion Committee Group (Corporate Authorship). Hijioka S, et al. Among authors: akita h. Clin Gastroenterol Hepatol. 2024 Apr 13:S1542-3565(24)00351-3. doi: 10.1016/j.cgh.2024.03.029. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38615727 Free article.
Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma.
Nishi H, Gotoh K, Tomimaru Y, Kobayashi S, Sasaki K, Iwagami Y, Yamada D, Akita H, Asaoka T, Noda T, Takahashi H, Tanemura M, Doki Y, Eguchi H. Nishi H, et al. Among authors: akita h. Cancer Chemother Pharmacol. 2023 Oct;92(4):303-314. doi: 10.1007/s00280-023-04531-w. Epub 2023 Jul 26. Cancer Chemother Pharmacol. 2023. PMID: 37491611 Free PMC article.
The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer.
Higashiguchi M, Murakami H, Akita H, Kobayashi S, Takahama S, Iwagami Y, Yamada D, Tomimaru Y, Noda T, Gotoh K, Doki Y, Yamamoto T, Eguchi H. Higashiguchi M, et al. Among authors: akita h. Oncol Rep. 2023 May;49(5):98. doi: 10.3892/or.2023.8535. Epub 2023 Mar 31. Oncol Rep. 2023. PMID: 36999632 Free PMC article.
186 results